We have placed human insulin receptor cDNA into a vector under the control of the simian virus 40 (SV40) early promoter and tested its function by transient expression in microinjected Xenopus oocytes and by expression in stably transformed CHO cells. The precursor and the a and 13 subunits of the receptor were detected by immunoprecipitation from extracts of these cells. The human insulin receptor expressed in CHO cells specifically binds 12-labeled insulin but not insulin-like growth factor I, displays insulin-stimulated autophosphorylation of the 13 subunit, and mediates insulinstimulated 2-deoxyglucose uptake. We conclude that the human insulin receptor Is synthesized, processed normally, and functional in this heterologous cell system. Diabetes mellitus is caused either by a deficiency of insulin or by insensitivity of the target cells to insulin. This latter defect causes the majority of diabetes, and its incidence appears to be increasing (1). An understanding of the defect in these patients requires an understanding of the molecular mechanisms ofinsulin action. The manifold insulin responses in target cells are initiated by the binding of insulin to its receptor, an integral membrane glycoprotein composed of two a (Mr 135,000) and two 13 subunits (Mr 95,000) (2, 3). Insulin binding to the a subunit (4) of the receptor results in stimulation of intrinsic phosphokinase activity of the P3 subunit and autophosphorylation predominantly on tyrosine residues (5, 6) . How this activity is related to the unique aspects of the insulin response is unknown.
Diabetes mellitus is caused either by a deficiency of insulin or by insensitivity of the target cells to insulin. This latter defect causes the majority of diabetes, and its incidence appears to be increasing (1) . An understanding of the defect in these patients requires an understanding of the molecular mechanisms ofinsulin action. The manifold insulin responses in target cells are initiated by the binding of insulin to its receptor, an integral membrane glycoprotein composed of two a (Mr 135,000) and two 13 subunits (Mr 95,000) (2, 3) . Insulin binding to the a subunit (4) of the receptor results in stimulation of intrinsic phosphokinase activity of the P3 subunit and autophosphorylation predominantly on tyrosine residues (5, 6) . How this activity is related to the unique aspects of the insulin response is unknown.
Recently the human insulin receptor cDNA has been cloned by Ebina et al. (7) and by Ullrich et al. (8) . The nucleotide sequence of the cDNA has revealed the primary structure of the single-chain insulin receptor precursor of 1382 amino acids (154 kDa). The a subunit (735 amino acids, 84 kDa) contains a cysteine-rich crosslinking domain; the 3-subunit (620 amino acids, 70 kDa) contains both the single transmembrane domain of the receptor and the tyrosine phosphokinase domain with the presumed ATP binding site and potential tyrosine phosphorylation sites (7, 8) . These features of the human insulin receptor and of the related epidermal growth factor receptor (9) provide the structural basis for understanding receptor function; they also intensify the mystery surrounding the specific biological effects associated with these molecules.
To elucidate the mechanism(s) of insulin action, the elements of the insulin receptor must somehow be functionally isolated and reconstituted. A heterologous cell system in which the receptor is expressed and then assayed for functional reconstitution would provide an experimental system in which the biological response of the cell to insulin could be explored ultimately in molecular detail. In (12) were introduced into cells by the calcium phosphate precipitation technique, with the addition of a glycerol shock after 4 hr (12) . After a 24-hr exposure to the DNA, the cells were trypsinized and replated at a 1:5 dilution. Within 24 hr, the antibiotic G418 (GIBCO) was added to the medium to a concentration of 400 ;Lg/ml. After 2 weeks, independent colonies were picked using trypsin/EDTA-saturated 3MM paper discs and transferred to a 24-well plate. When confluent, the cells were incubated with a monoclonal antibody (10 nM) specific for the human insulin receptor (10) for 1 hr at 40C. After washing, the cells were incubated with affinitypurified '25I-labeled rabbit anti-mouse IgG (10- Ci/mmol; 1 Ci = 37 GBq) and penicillin, streptomycin, and gentamycin. After 44 hr at 21'C the oocytes were harvested, rinsed with MBSH, and homogenized in 1 ml of 20 mM Tris Cl, pH 8.1/150 mM NaCl/1 mM EDTA/1% (vol/vol) Nonidet P-40 (NP-40)/1% sodium deoxycholate/0.1% NaDodSO4/ 1% aprotinin/1 mM phenylmethylsulfonyl fluoride. Pigment and yolk were removed by centrifugation (20,000 x g, 20 min). The supernatant was divided into two portions and subjected to immunoprecipitation overnight at 4°C with either a control monoclonal antibody or a pool of monoclonal antibodies that recognize both the a and ,B subunits of the insulin receptor (13) . In both cases, the antibodies were used in a preformed complex with formalin-fixed Staphylococcus aureus (Pansorbin, Calbiochem), with rabbit anti-mouse IgG (Cappel Laboratories) as a bridge. After immunoprecipitation the complex was washed extensively. Bound proteins were released by heating with NaDodSO4/PAGE sample buffer and half the sample was electrophoresed in a 1o gel (14) . 1255 Ci/mmol, 50 ,tCi/ml) and then for 4 hr with medium containing unlabeled methionine. An NP-40 (1%) extract was made from each culture, and labeled protein was immunoprecipitated using either normal mouse IgG or human insulin receptor-specific monoclonal antibody as described (10) . 35S-labeled proteins were visualized by autoradiography (without fluorography) of the gel with Kodak X-Omat film for 52 hr at -70°C. Molecular weights were calibrated using '4C-labeled protein standards (Amersham).
RNA Blot-Hybridization Analysis. Cells were grown in a 6-cm diameter dish and, before confluent, were washed twice with PBS and once with Tris-buffered saline (TBS: 20 mM Tris Cl, pH 7.5/150 mM NaCl). Cells were scraped off the plate with 0.4 ml ofTBS/0.5% NP-40 and were mixed briefly, on a Vortex, in a 1.5-ml Eppendorftube. Nuclei were pelleted in a microcentrifuge (30 sec at 4°C), and NaDodSO4 was added to the supernatant fluid to a final concentration of 0.5%. Following phenol/chloroform (3 times) and chloroform (1 time) extraction, the RNA was precipitated by addition of 1 ml of cold ethanol. Twelve micrograms of total RNA was electrophoresed in a formaldehyde/agarose gel, transferred to nitrocellulose (15) and hybridized with a nick-translated Pst I-EcoRI (1.5 kb) fragment of the human insulin receptor cDNA (7) . 28S (2 mM) were added, and the reaction continued for 60 min at 240C.
The reaction was stopped by the addition of 1% NaDodSO4, and samples were treated with 2-mercaptoethanol and analyzed by NaDodSO4/PAGE (14) . Following autoradiography, the labeled /3-subunit bands (Mr 95,000) were cut out for liquid scintillation counting.
Insulin Stimulation of 2-Deoxy[3H1glucose Uptake. CHO-HIR3 or control CHO cells were plated as for the binding studies. After reaching confluence, the cells were washed and incubated in buffer containing 140 mM NaCl, 1.7 mM KCl, 0.9 mM CaCl2, 1.47 mM potassium phosphate, and 0.1% bovine serum albumin at pH 7.4. After 30 min at 370C with the indicated concentration of insulin, the cells were incubated for 10 min with 0.1 mM 2-deoxy-D-[1,2-3H(N)]glucose (0.4 mCi/ml, New England Nuclear). Cells then were washed three times with ice-cold buffer containing 100 mM phloretin and were solubilized with 0.03% NaDodSO4; aliquots were assayed for protein and radioactivity. 
RESULTS AND DISCUSSION
An expression plasmid, pcDL1-HIR7, containing the entire coding sequence of the human insulin receptor cDNA (7), was constructed (Fig. 1) . In this vector the human insulin receptor cDNA is placed under the transcriptional control of the early promoter of SV40. The transcriptional unit is completed with the SV40 late-region introns and polyadenylylation signal.
We first tested the ability of this plasmid (pcDLl-HIR7) to express the human insulin receptor in Xenopus oocytes. (1985) detergent (NP-40) extracts were prepared from control and injected oocytes and incubated with insulin receptor-specific monoclonal antibodies. These antibodies specifically immunoprecipitated three labeled polypeptides from the extract of injected oocytes; the apparent Mrs (200,000, 135,000, and 95,000; Fig. 2 , lane 2) are consistent with those of the insulin receptor precursor and a and (3 subunits, respectively (16) . These proteins were not precipitated from control oocytes (Fig. 2, lane 4) , by the control antibody (lanes 1 and 3) , or from mock-injected oocytes (data not shown). Thus the injection of the expression vector into oocytes not only results in the synthesis of a protein of the size expected for the human insulin receptor precursor, but also in the processing of the precursor into the a and (3 subunits.
For further studies, we established stable rodent [CHO, rat hepatoma (HTC), and mouse L (LTA)] cell lines by cotransfection of the human insulin receptor expression plasmid, pcDL1-HIR7, with a plasmid conferring resistance to the neomycin analog G418 (see legend to Fig. 1) . Twentyfive, 12 , and 19 G418-resistant colonies were picked randomly from about 100 colonies of CHO, HTC, and LTA cell lines, respectively. These permanent cell lines were assayed for the presence of the human insulin receptor on the cell surface by selective binding of a monoclonal antibody specific for the human insulin receptor. This monoclonal antibody also blocks binding of insulin to human cells (10 3a). The sizes of the insulin receptor mRNAs in human cells range from 5 to 11 kb (7, 8) . No cross-hybridizing species were detected in control CHO cell RNA.
To examine the protein expressed in these cells, we immunoprecipitated metabolically labeled ([35S]methionine) proteins from nonionic detergent extracts of CHO-HIR3 and CHO cells (Fig. 3b) . Two polypeptides of Mr =135,000 and 95,000 (corresponding to the a and ( subunits, respectively) were immunoprecipitated from CHO-HIR3 (lane 4) but not CHO (lane 2) cells by the human insulin receptor-specific monoclonal antibody. Normal mouse IgG did not immunoprecipitate these proteins (lanes 1 and 3) . We conclude that the transfected rodent cells, like the Xenopus oocyte, process the insulin receptor precursor into mature a and (3 subunits.
The specificity of ligand binding was examined by assaying binding of '251-labeled insulin or insulin-like growth factor I (IGF-I) to CHO-HIR3 cells and CHO cells (Fig. 4a) . In the absence of unlabeled insulin, 1.8% of the 1251-labeled insulin was specifically bound by CHO-HIR3 cells, whereas only 0.5% was bound by control CHO cells. The binding of 125I-labeled insulin to both of these cell lines was inhibited in a dose-dependent fashion by unlabeled insulin. The human insulin receptor-specific monoclonal antibody blocked insulin binding, with progressively increasing effectiveness at higher concentrations, to CHO-HIR3 but not CHO cells (Fig.  4a) , indicating that the increased binding observed in the transfected cells is via the human insulin receptor. In contrast, both cell types bound 0.4% of 125I-labeled IGF-I (data not shown). This confirms the previous conclusion that the isolated cDNA encodes the human insulin receptor and not the IGF-I receptor (7) . It also indicates that the human insulin receptor binds little IGF-I under these conditions. The binding of 125I-labeled insulin is inhibited competitively by unlabeled insulin at lower concentrations (Fig. 4a) . The inhibition takes the form of a typical dissociation curve. At higher concentrations, the analysis is complicated by the known binding of insulin to IGF-I receptors (17) and by negative cooperativity (18 (Fig. 4b) . The incorporation of 32P into the subunit was 10 times greater in CHO-HIR3 cells than in CHO cells in both the presence and the absence of insulin. Insulin stimulated the observed phosphorylation 2-fold in both the CHO-HIR3 and the control CHO cells.
The 10-fold increase in phosphokinase activity observed in these preparations is significantly greater than the 5-fold increase in the number of cell surface insulin receptors detected on intact CHO-HIR3 cells. However, the 10-fold increase correlates well with the number of receptors detected in total cellular extracts by immunoassay (data not shown). Thus the difference is accounted for by an increased level of intracellular human insulin receptor in CHO-HIR3 cells.
To assess whether the human insulin receptor expressed in the CHO-HIR3 cells exhibits a physiological response, we assayed the insulin stimulation of glucose uptake. In initial experiments, it was found that 10 pM insulin stimulated 2-deoxyglucose uptake 15% in CHO cells and 75% in CHO-HIR3 cells. This led to a more systematic study of the insulin response, in which we varied the insulin concentration over four orders of magnitude (Fig. 4c) . The maximal stimulation by insulin of glucose uptake by both CHO-HIR3 cells and CHO cells was similar (=100%), but the insulin levels required for this effect were dramatically different for the two cell lines. This increase in sensitivity was confirmed in four separate experiments. For one-half the maximal response, CHO cells required an =30 times greater concentration of insulin than CHO-HIR3 cells. The increased sensitivity is not due to an increased affinity, since the estimated dissociation constants for the human and the hamster insulin receptors are very similar (Fig. 4a) . From the apparent dissociation constant, we calculated that 417% of the cell surface receptors (-%500 per cell) must be occupied for half-maximal response in CHO cells, whereas only 0.8% ofthe total receptors (-100) must be occupied for half-maximal response in CHO-HIR3 cells. Thus, there are "spare" receptors in both cell types (22) . The number of occupied receptors required for the biological response appears to be significantly different in the two cell types. This implies either that the human receptors expressed in CHO-HIR3 cells are more effective in transducing the insulin signal than are the endogenous receptors or that the receptors in CHO-HIR3 cells are in a different functional state [e.g., more effective clusters (23, 24) of the receptors might be generated at the higher receptor concentrations present in the membrane of CHO-HIR3 cells].
The ability to express the human insulin receptor in this heterologous cell system permits the further analysis of structure-function relationships of the receptor molecule and the role it plays in eliciting the various physiological responses to insulin. 
